EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
Special Offer: Just $199
×
S&P 500   3,950.36 (-0.34%)
DOW   33,790.64 (-0.17%)
QQQ   279.85 (-1.01%)
AAPL   140.48 (-2.59%)
MSFT   239.65 (-0.87%)
META   109.78 (+0.92%)
GOOGL   94.83 (-1.27%)
AMZN   92.15 (-1.92%)
TSLA   179.54 (-1.85%)
NVDA   156.21 (-1.30%)
NIO   10.54 (+4.15%)
BABA   79.79 (+5.15%)
AMD   73.48 (+0.40%)
T   18.91 (+0.48%)
MU   54.95 (-1.43%)
CGC   3.45 (+1.47%)
F   13.73 (+0.00%)
GE   85.23 (-0.28%)
DIS   94.09 (-1.67%)
AMC   7.41 (+1.09%)
PYPL   77.76 (-2.71%)
PFE   49.42 (-0.30%)
NFLX   279.18 (-0.71%)
S&P 500   3,950.36 (-0.34%)
DOW   33,790.64 (-0.17%)
QQQ   279.85 (-1.01%)
AAPL   140.48 (-2.59%)
MSFT   239.65 (-0.87%)
META   109.78 (+0.92%)
GOOGL   94.83 (-1.27%)
AMZN   92.15 (-1.92%)
TSLA   179.54 (-1.85%)
NVDA   156.21 (-1.30%)
NIO   10.54 (+4.15%)
BABA   79.79 (+5.15%)
AMD   73.48 (+0.40%)
T   18.91 (+0.48%)
MU   54.95 (-1.43%)
CGC   3.45 (+1.47%)
F   13.73 (+0.00%)
GE   85.23 (-0.28%)
DIS   94.09 (-1.67%)
AMC   7.41 (+1.09%)
PYPL   77.76 (-2.71%)
PFE   49.42 (-0.30%)
NFLX   279.18 (-0.71%)
S&P 500   3,950.36 (-0.34%)
DOW   33,790.64 (-0.17%)
QQQ   279.85 (-1.01%)
AAPL   140.48 (-2.59%)
MSFT   239.65 (-0.87%)
META   109.78 (+0.92%)
GOOGL   94.83 (-1.27%)
AMZN   92.15 (-1.92%)
TSLA   179.54 (-1.85%)
NVDA   156.21 (-1.30%)
NIO   10.54 (+4.15%)
BABA   79.79 (+5.15%)
AMD   73.48 (+0.40%)
T   18.91 (+0.48%)
MU   54.95 (-1.43%)
CGC   3.45 (+1.47%)
F   13.73 (+0.00%)
GE   85.23 (-0.28%)
DIS   94.09 (-1.67%)
AMC   7.41 (+1.09%)
PYPL   77.76 (-2.71%)
PFE   49.42 (-0.30%)
NFLX   279.18 (-0.71%)
S&P 500   3,950.36 (-0.34%)
DOW   33,790.64 (-0.17%)
QQQ   279.85 (-1.01%)
AAPL   140.48 (-2.59%)
MSFT   239.65 (-0.87%)
META   109.78 (+0.92%)
GOOGL   94.83 (-1.27%)
AMZN   92.15 (-1.92%)
TSLA   179.54 (-1.85%)
NVDA   156.21 (-1.30%)
NIO   10.54 (+4.15%)
BABA   79.79 (+5.15%)
AMD   73.48 (+0.40%)
T   18.91 (+0.48%)
MU   54.95 (-1.43%)
CGC   3.45 (+1.47%)
F   13.73 (+0.00%)
GE   85.23 (-0.28%)
DIS   94.09 (-1.67%)
AMC   7.41 (+1.09%)
PYPL   77.76 (-2.71%)
PFE   49.42 (-0.30%)
NFLX   279.18 (-0.71%)
NYSE:JNJ

Johnson & Johnson - JNJ Stock Forecast, Price & News

$176.14
-1.19 (-0.67%)
(As of 11/29/2022 02:51 PM ET)
Add
Compare
Today's Range
$174.67
▼
$177.49
50-Day Range
$160.20
▼
$177.33
52-Week Range
$155.72
▼
$186.69
Volume
281,938 shs
Average Volume
6.00 million shs
Market Capitalization
$460.51 billion
P/E Ratio
24.53
Dividend Yield
2.55%
Price Target
$181.33

Johnson & Johnson MarketRank™ Forecast

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
3.4% Upside
$181.33 Price Target
Short Interest
Healthy
0.49% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.98
Upright™ Environmental Score
News Sentiment
0.37mentions of Johnson & Johnson in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$36.79 M Sold Last Quarter
Proj. Earnings Growth
2.29%
From $10.04 to $10.27 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

143rd out of 1,038 stocks

Pharmaceutical Preparations Industry

50th out of 510 stocks

See Top Rated MarketRank™ Stocks Here
JNJ stock logo

About Johnson & Johnson (NYSE:JNJ) Stock

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Receive JNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

JNJ Stock News Headlines

November 16, 2022 | marketbeat.com
Four Healthcare Stocks To Watch This Week (JNJ)
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.
November 16, 2022 | marketbeat.com
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market? (JNJ)
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
November 29, 2022 | Investing Trends (Ad)
Why is Russia reopening dormant copper mines?
In deepest Siberia, Russian oligarchs are pouring $15 billion into two long-dormant copper mines with close access to the lucrative China market. Copper is essential to the West's plans to transition to green energy and Russia has the third-largest reserves in the world. Is Putin making a move to corner the copper market? New sources of copper – outside Russia – are desperately needed for the West to win its war for energy independence.
November 7, 2022 | dividendstocks.com
Blue Chip Stocks and Dividend Yields (JNJ)
November 4, 2022 | marketbeat.com
How to Invest in Blue Chip Stocks (JNJ)
Blue-chip stocks are a winning target for safety and dividends, but not all blue chips are the same. Learn more about how to invest in blue chip stocks.
November 2, 2022 | marketbeat.com
Stocks fall after Fed says rates may rise more than expected
Stocks fell sharply after Federal Reserve Chair Jerome Powell signaled that interest rates may need to go even higher than previously thought in order to tame the worst inflation in decades
November 1, 2022 | marketbeat.com
Asian benchmarks higher as markets await Fed rate moves
Asian shares are mostly higher ahead of a decision by the U.S. Federal Reserve on an interest rate increase to curb inflation
November 1, 2022 | marketbeat.com
US futures advance ahead of Fed open policy meeting
Wall Street pointed higher in premarket trading on Tuesday as Federal Reserve officials prepared to open their latest policy meeting where its expected they will raise the central bank’s main borrowing rate for the sixth time this year
November 29, 2022 | Investing Trends (Ad)
Why is Russia reopening dormant copper mines?
In deepest Siberia, Russian oligarchs are pouring $15 billion into two long-dormant copper mines with close access to the lucrative China market. Copper is essential to the West's plans to transition to green energy and Russia has the third-largest reserves in the world. Is Putin making a move to corner the copper market? New sources of copper – outside Russia – are desperately needed for the West to win its war for energy independence.
November 1, 2022 | marketbeat.com
J&J to buy cardio technology company Abiomed for $16.6B
Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division
November 1, 2022 | marketbeat.com
J&J to buy cardiovascular technology Abiomed in $16.6B deal
Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division
November 27, 2022 | finance.yahoo.com
15 Biggest Holding Companies in the World
November 27, 2022 | finance.yahoo.com
Up 32% in 2022, Is Eli Lilly Stock Still a Buy?
November 25, 2022 | benzinga.com
Thinking about buying stock in Cosmos Holdings, Coupa Software, VEON, Johnson & Johnson, or HP?
November 24, 2022 | benzinga.com
EVP of Johnson & Johnson Makes $13.60M Sale
November 23, 2022 | finance.yahoo.com
2 Safe Dividend Stocks to Buy Hand Over Fist
November 23, 2022 | forbes.com
This Pharmaceutical Company Is A Better Pick Over Johnson & Johnson Stock
November 23, 2022 | americanbankingnews.com
Robert J. Decker Sells 16,928 Shares of Johnson & Johnson (NYSE:JNJ) Stock
November 22, 2022 | benzinga.com
Controller of Johnson & Johnson Sold $2.96M In Stock
November 21, 2022 | stocknews.com
3 Stocks Seasoned Investors on Wall Street Love to Buy
November 21, 2022 | americanbankingnews.com
Johnson & Johnson (NYSE:JNJ) Research Coverage Started at Credit Suisse Group
November 20, 2022 | finance.yahoo.com
The average 401(k) balance plunged a nasty $29,000 over the past year — but these 3 large-cap stocks have protected investors from the pain (and could do it again in 2023)
November 18, 2022 | markets.businessinsider.com
Analyst Ratings for Johnson & Johnson
November 18, 2022 | markets.businessinsider.com
7 Analysts Have This to Say About Johnson & Johnson
November 17, 2022 | msn.com
A Look Into Johnson & Johnson's Debt
November 17, 2022 | finance.yahoo.com
Johnson & Johnson (JNJ) Up 5.3% Since Last Earnings Report: Can It Continue?
November 15, 2022 | msn.com
Dow's 100-point jump highlighted by gains in Merck, Johnson & Johnson stocks
See More Headlines
Receive JNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

JNJ Company Calendar

Ex-Dividend for 9/6 Dividend
8/22/2022
Dividend Payable
9/06/2022
Last Earnings
10/18/2022
Ex-Dividend for 12/6 Dividend
11/21/2022
Today
11/29/2022
Dividend Payable
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
1/24/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
Current Symbol
NYSE:JNJ
CUSIP
47816010
CIK
200406
Web
www.jnj.com
Phone
(732) 524-0400
Fax
732-214-0332
Employees
141,700
Year Founded
1886

Price Target and Rating

Average Stock Price Forecast
$181.33
High Stock Price Forecast
$198.00
Low Stock Price Forecast
$160.00
Forecasted Upside/Downside
+2.9%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
11 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$7.18
Trailing P/E Ratio
24.53
Forward P/E Ratio
17.54
P/E Growth
3.51
Net Income
$20.88 billion
Net Margins
19.95%
Pretax Margin
23.28%
Return on Equity
35.37%
Return on Assets
14.86%

Debt

Debt-to-Equity Ratio
0.37
Current Ratio
1.43
Quick Ratio
1.18

Sales & Book Value

Annual Sales
$93.78 billion
Price / Sales
4.91
Cash Flow
$12.68 per share
Price / Cash Flow
13.89
Book Value
$28.12 per share
Price / Book
6.26

Miscellaneous

Outstanding Shares
2,614,480,000
Free Float
2,605,333,000
Market Cap
$460.51 billion
Optionable
Optionable
Beta
0.57

Social Links


Key Executives

  • Mr. Alex GorskyMr. Alex Gorsky (Age 62)
    Exec. Chairman
    Comp: $6.18M
  • Mr. Joaquin DuatoMr. Joaquin Duato (Age 59)
    CEO & Director
    Comp: $3.53M
  • Mr. Joseph J. Wolk CPA (Age 55)
    Exec. VP & CFO
    Comp: $2.58M
  • Ms. Jennifer L. Taubert (Age 58)
    Exec. VP & Worldwide Chairman of Pharmaceuticals
    Comp: $2.5M
  • Mr. Robert J. Decker Jr.Mr. Robert J. Decker Jr. (Age 50)
    Controller & Chief Accounting Officer
  • Mr. James Swanson
    Exec. VP & Chief Information Officer
  • Ms. Jessica Moore
    VP of Investor Relations
  • Mr. Dirk Brinckman
    Chief Compliance Officer
  • Ms. Elizabeth Forminard
    Exec. VP & Gen. Counsel
  • Dr. Peter M. Fasolo Ph.D. (Age 59)
    Exec. VP & Chief HR Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













JNJ Stock - Frequently Asked Questions

Should I buy or sell Johnson & Johnson stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last twelve months. There are currently 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" JNJ shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JNJ, but not buy additional shares or sell existing shares.
View JNJ analyst ratings or view top-rated stocks.

What is Johnson & Johnson's stock price forecast for 2023?

11 Wall Street research analysts have issued 12 month price targets for Johnson & Johnson's shares. Their JNJ share price forecasts range from $160.00 to $198.00. On average, they expect the company's stock price to reach $181.33 in the next twelve months. This suggests a possible upside of 3.1% from the stock's current price.
View analysts price targets for JNJ or view top-rated stocks among Wall Street analysts.

How have JNJ shares performed in 2022?

Johnson & Johnson's stock was trading at $171.07 at the start of the year. Since then, JNJ shares have increased by 2.8% and is now trading at $175.91.
View the best growth stocks for 2022 here.

Are investors shorting Johnson & Johnson?

Johnson & Johnson saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 12,350,000 shares, an increase of 10.0% from the October 15th total of 11,230,000 shares. Based on an average daily volume of 7,220,000 shares, the short-interest ratio is currently 1.7 days. Currently, 0.5% of the shares of the company are short sold.
View Johnson & Johnson's Short Interest.

When is Johnson & Johnson's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, January 24th 2023.
View our JNJ earnings forecast.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) posted its quarterly earnings data on Tuesday, October, 18th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.49 by $0.06. The firm earned $23.79 billion during the quarter, compared to analyst estimates of $23.44 billion. Johnson & Johnson had a net margin of 19.95% and a trailing twelve-month return on equity of 35.37%. The business's revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the business posted $2.60 EPS.
Read the conference call transcript.

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Wednesday, October 19th. Investors of record on Tuesday, November 22nd will be paid a dividend of $1.13 per share on Tuesday, December 6th. This represents a $4.52 annualized dividend and a dividend yield of 2.57%. The ex-dividend date is Monday, November 21st.
Read our dividend analysis for JNJ.

Is Johnson & Johnson a good dividend stock?

Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.52 per share and currently has a dividend yield of 2.55%. The company has been increasing its dividend for 60 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 62.95%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, JNJ will have a dividend payout ratio of 44.01% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for JNJ.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson declared that its board has authorized a stock buyback program on Wednesday, September 14th 2022, which allows the company to repurchase $5,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 1.2% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson issued an update on its FY 2022 earnings guidance on Wednesday, November, 2nd. The company provided earnings per share guidance of $10.02-$10.07 for the period, compared to the consensus EPS estimate of $10.03. The company issued revenue guidance of $93.00 billion-$93.50 billion, compared to the consensus revenue estimate of $94.85 billion.

What is Alex Gorsky's approval rating as Johnson & Johnson's CEO?

2,535 employees have rated Johnson & Johnson Chief Executive Officer Alex Gorsky on Glassdoor.com. Alex Gorsky has an approval rating of 94% among the company's employees. This puts Alex Gorsky in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), Walt Disney (DIS), NVIDIA (NVDA), Intel (INTC), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Procter & Gamble (PG) and AbbVie (ABBV).

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.38%), BlackRock Inc. (7.65%), State Street Corp (5.43%), Bank of New York Mellon Corp (1.21%), Price T Rowe Associates Inc. MD (0.97%) and Massachusetts Financial Services Co. MA (0.87%). Insiders that own company stock include Ashley Mcevoy, Hubert Joly, Jennifer L Taubert, Kathryn E Wengel, Michael E Sneed, Peter Fasolo, Robert J Decker, Thibaut Mongon, William D Perez and William Hait.
View institutional ownership trends.

How do I buy shares of Johnson & Johnson?

Shares of JNJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $175.91.

How much money does Johnson & Johnson make?

Johnson & Johnson (NYSE:JNJ) has a market capitalization of $459.91 billion and generates $93.78 billion in revenue each year. The company earns $20.88 billion in net income (profit) each year or $7.18 on an earnings per share basis.

How many employees does Johnson & Johnson have?

The company employs 141,700 workers across the globe.

Does Johnson & Johnson have any subsidiaries?
The following companies are subsidiares of Johnson & Johnson: 3Dintegrated ApS, ALZA Corporation, AMO (Hangzhou) Co. Ltd., AMO (Shanghai) Medical Devices Trading Co. Ltd Beijing Branch, AMO (Shanghai) Medical Devices Trading Co. Ltd Guangzhou Branch, AMO (Shanghai) Medical Devices Trading Co. Ltd., AMO ASIA LIMITED, AMO Asia Limited (Korea Branch), AMO Asia Limited Taiwan Branch (Hong Kong), AMO Australia Pty Limited, AMO Australia Pty Limited (New Zealand Branch), AMO Canada Company, AMO Denmark ApS, AMO Development LLC, AMO France, AMO Germany GmbH, AMO Groningen B.V., AMO International Holdings Unlimited Company, AMO Ireland, AMO Ireland Ireland Branch, AMO Italy SRL, AMO Japan K.K., AMO Manufacturing USA LLC, AMO Netherlands BV, AMO Nominee Holdings LLC, AMO Norway AS, AMO Puerto Rico Manufacturing Inc., AMO Sales and Service Inc., AMO Singapore Pte. Ltd., AMO Spain Holdings LLC, AMO Switzerland GmbH, AMO U.K. Holdings LLC, AMO United Kingdom Ltd., AMO Uppsala AB, AUB Holdings LLC, Abott Medical Optics, Acclarent Inc., Actelion Ltd, Actelion Pharmaceuticals, Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd., Actelion Pharmaceuticals US Inc., Actelion Treasury Unlimited Company, Akros Medical Inc., Albany Street LLC, Alios BioPharma, Alza Land Management Inc., Anakuria Therapeutics Inc., Animas Diabetes Care LLC, Animas LLC, Animas Technologies LLC, AorTx Inc., Apsis, Aragon Pharmaceuticals, Aragon Pharmaceuticals Inc., Asia Pacific Holdings LLC, Atrionix Inc., Auris Health, Auris Health Inc., Backsvalan 2 Aktiebolag, Backsvalan 6 Handelsbolag, Beijing Dabao Cosmetics Co. Ltd., BeneVir BioPharm Inc., Berna Rhein B.V., BioMedical Enterprises Inc., Biosense Webster (Israel) Ltd., Biosense Webster Inc., Branch of Johnson & Johnson LLC (RU) in Kazakhstan, C Consumer Products Denmark ApS, CSATS Inc., Calibra Medical LLC, Campus-Foyer Apotheke GmbH, Carlo Erba OTC S.r.l., Centocor Biologics LLC, Centocor Research & Development Inc., Cerenovus Inc., ChromaGenics B.V., Ci:Labo Customer Marketing Co. Ltd., Ci:Labo USA Inc., Ci:z Holdings, Ci:z. Labo Co. Ltd., Cilag AG, Cilag GmbH International, Cilag Holding AG, Cilag Holding Treasury Unlimited Company, Cilag-Biotech S.L., CoTherix Inc., Coherex Medical Inc., ColBar LifeScience Ltd., Company Store.com Inc., Conor MedSystems, Cordis International Corporation, Cordis de Mexico S.A. de C.V., Corimmun GmbH, DePuy Hellas SA, DePuy International Limited, DePuy Ireland Unlimited Company, DePuy Mexico S.A. de C.V., DePuy Mitek LLC, DePuy Orthopaedics Inc., DePuy Products Inc., DePuy Spine LLC, DePuy Synthes Gorgan Limited, DePuy Synthes Inc., DePuy Synthes Institute LLC, DePuy Synthes Leto SARL, DePuy Synthes Products Inc., DePuy Synthes Sales Inc., Debs-Vogue Corporation (Proprietary) Limited, Dutch Holding LLC, ECL7 LLC, EES Holdings de Mexico S. de R.L. de C.V., EES S.A. de C.V., EIT Emerging Implant Technologies GmbH, Ethicon Endo-Surgery (Europe) GmbH, Ethicon Endo-Surgery Inc., Ethicon Endo-Surgery LLC, Ethicon Inc., Ethicon LLC, Ethicon PR Holdings Unlimited Company, Ethicon Sarl, Ethicon US LLC, Ethicon Women's Health & Urology Sarl, Ethnor (Proprietary) Limited, Ethnor Farmaceutica S.A., Ethnor del Istmo S.A., FMS Future Medical System SA, Finsbury (Development) Limited, Finsbury (Instruments) Limited, Finsbury Medical Limited, Finsbury Orthopaedics International Limited, Finsbury Orthopaedics Limited, GH Biotech Holdings Limited, GMED Healthcare BV, GMED Healthcare BV (Branch), Global Investment Participation B.V., Guangzhou Bioseal Biotech Co. Ltd., Hansen Medical Deutschland GmbH, Hansen Medical Inc., Hansen Medical International Inc., Hansen Medical UK Limited, Healthcare Services (Shanghai) Ltd., Hickory Merger Sub Inc., I.D. Acquisition Corp., Innomedic Gesellschaft für innovative Medizintechnik und Informatik mbH, Innovative Surgical Solutions LLC, J & J Company West Africa Limited, J&J Pension Trustees Limited, J-C Health Care Ltd., J.C. General Services BV, JJ Surgical Vision Spain S.L., JJC Acquisition Company B.V., JJHC LLC, JJSV Belgium BV, JJSV Manufacturing Malaysia SDN. BHD., JJSV Norden AB, JJSV Produtos Oticos Ltda., JNJ Global Business Services s.r.o., JNJ Holding EMEA B.V., JNJ International Investment LLC, JOM Pharmaceutical Services Inc., Janssen Alzheimer Immunotherapy (Holding) Limited, Janssen BioPharma LLC, Janssen Biologics (Ireland) Limited, Janssen Biologics B.V., Janssen Biotech Inc., Janssen Cilag C.A., Janssen Cilag Farmaceutica S.A., Janssen Cilag S.p.A., Janssen Cilag SPA, Janssen Development Finance Unlimited Company, Janssen Diagnostics LLC, Janssen Egypt LLC, Janssen Farmaceutica Portugal Lda, Janssen Global Services LLC, Janssen Holding GmbH, Janssen Inc., Janssen Irish Finance Unlimited Company, Janssen Korea Ltd., Janssen Oncology Inc., Janssen Ortho LLC, Janssen Pharmaceutica (Proprietary) Limited, Janssen Pharmaceutica NV, Janssen Pharmaceutica S.A., Janssen Pharmaceutical K.K., Janssen Pharmaceutical Sciences Unlimited Company, Janssen Pharmaceutical Unlimited Company, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals Inc. Japan Branch, Janssen Products LP, Janssen R&D Ireland Unlimited Company, Janssen Research & Development LLC, Janssen Sciences Ireland Unlimited Company, Janssen Scientific Affairs LLC, Janssen Supply Group LLC, Janssen Vaccines & Prevention B.V., Janssen Vaccines Branch of Cilag GmbH International, Janssen Vaccines Corp., Janssen-Cilag, Janssen-Cilag (New Zealand) Limited, Janssen-Cilag A/S, Janssen-Cilag AG, Janssen-Cilag AS, Janssen-Cilag Aktiebolag, Janssen-Cilag B.V., Janssen-Cilag Farmaceutica Lda., Janssen-Cilag Farmaceutica Ltda., Janssen-Cilag GmbH, Janssen-Cilag International NV, Janssen-Cilag Kft., Janssen-Cilag Kft. Branch Office, Janssen-Cilag Limited, Janssen-Cilag Manufacturing LLC, Janssen-Cilag NV, Janssen-Cilag OY, Janssen-Cilag Pharma GmbH, Janssen-Cilag Pharmaceutical S.A.C.I., Janssen-Cilag Polska Sp. z o.o., Janssen-Cilag Pty Ltd, Janssen-Cilag Pty Ltd (Branch), Janssen-Cilag S.A., Janssen-Cilag S.A., Janssen-Cilag S.A. de C.V., Janssen-Cilag de Mexico S. de R.L. de C.V., Janssen-Cilag s.r.o., Janssen-Pharma S.L., Jevco Holding Inc., Johnson & Johnson, Johnson & Johnson (Angola) Limitada, Johnson & Johnson (China) Investment Ltd., Johnson & Johnson (China) Investment Ltd. Beijing Branch, Johnson & Johnson (Egypt) S.A.E., Johnson & Johnson (Hong Kong) Limited, Johnson & Johnson (Ireland) Limited, Johnson & Johnson (Jamaica) Limited, Johnson & Johnson (Kenya) Limited, Johnson & Johnson (Middle East) Inc., Johnson & Johnson (Middle East) Inc. (DHCC Branch), Johnson & Johnson (Middle East) Inc. (JAFZA Branch), Johnson & Johnson (Middle East) Inc. Service Center (DAFZA Branch), Johnson & Johnson (Mozambique) Limitada, Johnson & Johnson (Namibia) (Proprietary) Limited, Johnson & Johnson (New Zealand) Limited, Johnson & Johnson (Philippines) Inc., Johnson & Johnson (Private) Limited, Johnson & Johnson (Thailand) Ltd., Johnson & Johnson (Trinidad) Limited, Johnson & Johnson (Vietnam) Co. Ltd, Johnson & Johnson - Societa' Per Azioni, Johnson & Johnson AB, Johnson & Johnson AB Eesti filiaal (Branch), Johnson & Johnson AG, Johnson & Johnson AG (Zuchwil Branch), Johnson & Johnson Belgium Finance Company BV, Johnson & Johnson Bulgaria EOOD, Johnson & Johnson China Ltd., Johnson & Johnson Consumer (Hong Kong) Limited, Johnson & Johnson Consumer (Thailand) Limited, Johnson & Johnson Consumer B.V., Johnson & Johnson Consumer Health Care Switzerland Branch of Janssen-Cilag AG, Johnson & Johnson Consumer Holdings France, Johnson & Johnson Consumer Inc., Johnson & Johnson Consumer Inc. (Dominican Republic Branch), Johnson & Johnson Consumer NV, Johnson & Johnson Consumer Saudi Arabia Limited, Johnson & Johnson Consumer Services EAME Ltd., Johnson & Johnson Del Paraguay S.A., Johnson & Johnson Dominicana S.A.S., Johnson & Johnson Enterprise Innovation Inc., Johnson & Johnson European Treasury Unlimited Company, Johnson & Johnson Finance Corporation, Johnson & Johnson Finance Limited, Johnson & Johnson Financial Services GmbH, Johnson & Johnson Financial Services GmbH (Branch Office), Johnson & Johnson Gateway LLC, Johnson & Johnson Gesellschaft m.b.H., Johnson & Johnson GmbH, Johnson & Johnson Guatemala S.A., Johnson & Johnson Health Care Systems Inc., Johnson & Johnson Health and Wellness Solutions Inc., Johnson & Johnson Hellas Commercial and Industrial S.A., Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme, Johnson & Johnson Hemisferica S.A., Johnson & Johnson Holding GmbH, Johnson & Johnson Inc., Johnson & Johnson Industrial Ltda., Johnson & Johnson Innovation - JJDC Inc., Johnson & Johnson Innovation LLC, Johnson & Johnson Innovation Limited, Johnson & Johnson International, Johnson & Johnson International (Belgian Branch) (European Logistics Center), Johnson & Johnson International (Singapore) Pte. Ltd., Johnson & Johnson International (Singapore) Pte. Ltd. (Branch), Johnson & Johnson International Financial Services Unlimited Company, Johnson & Johnson K.K., Johnson & Johnson Kft., Johnson & Johnson Korea Ltd., Johnson & Johnson Korea Selling & Distribution LLC, Johnson & Johnson LLC, Johnson & Johnson Lda, Johnson & Johnson Limited, Johnson & Johnson Limited (Sri Lanka Branch), Johnson & Johnson Luxembourg Finance Company Sarl, Johnson & Johnson Management Limited, Johnson & Johnson Medical (China) Ltd., Johnson & Johnson Medical (Proprietary) Ltd, Johnson & Johnson Medical (Shanghai) Ltd., Johnson & Johnson Medical (Shanghai) Ltd. Beijing Branch, Johnson & Johnson Medical (Suzhou) Ltd., Johnson & Johnson Medical B.V., Johnson & Johnson Medical Devices & Diagnostics Group - Latin America L.L.C., Johnson & Johnson Medical GmbH, Johnson & Johnson Medical Korea Ltd., Johnson & Johnson Medical Limited, Johnson & Johnson Medical Mexico S.A. de C.V., Johnson & Johnson Medical NV, Johnson & Johnson Medical Products GmbH, Johnson & Johnson Medical Pty Ltd, Johnson & Johnson Medical S.A., Johnson & Johnson Medical S.C.S., Johnson & Johnson Medical S.p.A., Johnson & Johnson Medical SAS, Johnson & Johnson Medical Saudi Arabia Limited, Johnson & Johnson Medical Taiwan Ltd., Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi, Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi (Ankara Branch), Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi (Izmir Branch), Johnson & Johnson Middle East - Scientific Office, Johnson & Johnson Middle East FZ - LLC (Lebanese Branch), Johnson & Johnson Middle East FZ-LLC, Johnson & Johnson Middle East FZ-LLC (Ghana Branch), Johnson & Johnson Middle East FZ-LLC (Kenya Branch), Johnson & Johnson Middle East FZ-LLC Branch (TSO) (Saudi Arabia Branch), Johnson & Johnson Morocco Societe Anonyme, Johnson & Johnson NCB (Belgian Branch), Johnson & Johnson Nordic AB, Johnson & Johnson Pacific Pty Limited, Johnson & Johnson Pakistan (Private) Limited, Johnson & Johnson Panama S.A., Johnson & Johnson Personal Care (Chile) S.A., Johnson & Johnson Poland Sp. z o.o., Johnson & Johnson Poland sp. z o.o. oddzial w Warszawie "Consumer", Johnson & Johnson Private Limited, Johnson & Johnson Pte. Ltd., Johnson & Johnson Pte. Ltd. Korea Branch, Johnson & Johnson Pty. Limited, Johnson & Johnson Romania S.R.L., Johnson & Johnson S.A., Johnson & Johnson S.A. de C.V., Johnson & Johnson S.E. Inc., Johnson & Johnson S.E. d.o.o., Johnson & Johnson SDN. BHD., Johnson & Johnson Sante Beaute France, Johnson & Johnson Services Inc., Johnson & Johnson Surgical Vision Inc., Johnson & Johnson Surgical Vision India Private Limited, Johnson & Johnson Taiwan Ltd., Johnson & Johnson UK Treasury Company Limited, Johnson & Johnson Ukraine LLC, Johnson & Johnson Urban Renewal Associates, Johnson & Johnson Vision Care (Shanghai) Ltd., Johnson & Johnson Vision Care Inc., Johnson & Johnson Vision Care Ireland Unlimited Company, Johnson & Johnson d.o.o., Johnson & Johnson de Argentina S.A.C. e. I., Johnson & Johnson de Chile Limitada, Johnson & Johnson de Chile S.A., Johnson & Johnson de Colombia S.A., Johnson & Johnson de Mexico S.A. de C.V., Johnson & Johnson de Uruguay S.A., Johnson & Johnson de Venezuela S.A., Johnson & Johnson del Ecuador S.A., Johnson & Johnson del Peru S.A., Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda., Johnson & Johnson for Export and Import LLC, Johnson & Johnson s.r.o., Johnson Y Johnson de Costa Rica S.A., Johnson and Johnson (Proprietary) Limited, Johnson and Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi, LTL Management LLC, La Concha Land Investment Corporation, Latam International Investment Company Unlimited Company, Legal Entity Name, MDS Co. Ltd., McNEIL MMP LLC, McNeil AB, McNeil Consumer Pharmaceuticals Co., McNeil Denmark ApS, McNeil Healthcare (Ireland) Limited, McNeil Healthcare (UK) Limited, McNeil Healthcare LLC, McNeil Iberica S.L.U., McNeil LA LLC, McNeil Nutritionals LLC, McNeil Panama LLC, McNeil Products Limited, McNeil Sweden AB, Medical Device Business Services Inc., Medical Devices & Diagnostics Global Services LLC, Medical Devices International LLC, Medos International Sarl, Medos International Sàrl succursale de Neuchâtel (Branch), Medos Sarl, MegaDyne Medical Products Inc., Menlo Care De Mexico S.A. de C.V., Mentor B.V., Mentor Deutschland GmbH, Mentor Medical Systems B.V., Mentor Partnership Holding Company I LLC, Mentor Texas GP LLC, Mentor Texas L.P., Mentor Worldwide LLC, Micrus Endovascular LLC, Middlesex Assurance Company Limited, Momenta Ireland Limited, Momenta Pharmaceuticals, Momenta Pharmaceuticals Inc., NeoStrata Company Inc., NeoStrata UG (haftungsbeschränkt), Netherlands Holding Company, NeuWave Medical Inc., Neuravi Limited, Novira Therapeutics, Novira Therapeutics LLC, NuVera Medical Inc., OBTECH Medical Sarl, OGX Beauty Limited, OMJ Holding GmbH, OMJ Ireland Unlimited Company, OMJ Pharmaceuticals Inc., Obtech Medical Mexico S.A. de C.V., Omrix Biopharmaceuticals Inc., Omrix Biopharmaceuticals Ltd., Omrix Biopharmaceuticals NV, Ortho Biologics LLC, Ortho Biotech Holding LLC, Ortho-McNeil Pharmaceutical LLC, Orthospin Ltd., Orthotaxy, PT Integrated Healthcare Indonesia, PT. Johnson & Johnson Indonesia, Patriot Pharmaceuticals LLC, Peninsula Pharmaceuticals LLC, Pharmadirect Ltd., Pharmedica Laboratories (Proprietary) Limited, Princeton Laboratories Inc., Productos de Cuidado Personal y de La Salud de Bolivia S.R.L., Proleader S.A., Pulsar Vascular Inc., Regency Urban Renewal Associates, RespiVert Ltd., RoC International, Royalty A&M LLC, Rutan Realty LLC, SYNTHES Medical Immobilien GmbH, Scios LLC, Sedona Singapore International Pte. Ltd., Sedona Thai International Co. Ltd., Serhum S.A. de C.V., Shanghai Elsker For Mother & Baby Co. Ltd, Shanghai Elsker Mother & Baby Co. Ltd Minghang Branch, Shanghai Johnson & Johnson Ltd., Shanghai Johnson & Johnson Pharmaceuticals Ltd., Sightbox LLC, Sodiac ESV, Spectrum Vision Limited Liability Company, Spectrum Vision Limited Liability Partnership, SterilMed, SterilMed Inc., Surgical Process Institute Deutschland GmbH, Synthes Costa Rica S.C.R. Limitada, Synthes GmbH, Synthes Holding AG, Synthes Holding Limited, Synthes Inc., Synthes Medical Surgical Equipment & Instruments Trading LLC, Synthes Produktions GmbH, Synthes Proprietary Limited, Synthes S.M.P. S. de R.L. de C.V., Synthes Tuttlingen GmbH, Synthes USA LLC, Synthes USA Products LLC, TARIS Biomedical, TARIS Biomedical LLC, TearScience Inc., The Anspach Effort LLC, The Vision Care Institute LLC, Tibotec LLC, Torax Medical Inc., UAB "Johnson & Johnson", UAB Johnson & Johnson Eesti Filiaal (Estonian Branch), Vania Expansion, Verb Surgical, Verb Surgical Inc., Vision Care Finance Unlimited Company, Vogue International, Vogue International LLC, Vogue International Trading Inc., WH4110 Development Company L.L.C., XO1, XO1 Limited, Xian Janssen Pharmaceutical Ltd., Xian-Janssen Pharmaceutical Ltd. Beijing Branch Office, Xian-Janssen Pharmaceutical Ltd. Shanghai Branch Office, Zarbee's Inc., and Zarbee's Naturals.
Read More
How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The official website for the company is www.jnj.com. The company can be reached via phone at (732) 524-0400 or via fax at 732-214-0332.

This page (NYSE:JNJ) was last updated on 11/29/2022 by MarketBeat.com Staff